We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+28.35%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.48B
AUM Growth
-$34.8M
Cap. Flow
-$328M
Cap. Flow %
-22.14%
Top 10 Hldgs %
6.75%
Holding
913
New
211
Increased
150
Reduced
301
Closed
241

Top Buys

Rank Stock Value
1
SMG icon
ScottsMiracle-Gro
SMG
+$5.68M
2
ACGL icon
Arch Capital
ACGL
+$5.65M
3
DDOG icon
Datadog
DDOG
+$5.54M
4
OLLI icon
Ollie's Bargain Outlet
OLLI
+$5.38M
5
NEE icon
NextEra Energy
NEE
+$5.27M

Sector Composition

Rank Sector Weight
1 Healthcare 22.47%
2 Technology 21.77%
3 Consumer Discretionary 18.47%
4 Industrials 10.54%
5 Financials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPZM
251
DELISTED
Epizyme, Inc
EPZM
$1.91M 0.13%
176,257
+29,795
+20% +$368K
ALXN
252
DELISTED
Alexion Pharmaceuticals
ALXN
$1.89M 0.13%
12,104
-43,647
-78% -$5.61M
HAPN
253
Happen Inc
HAPN
$2.14B
$1.89M 0.13%
178,862
+39,786
+29% +$266K
XNCR icon
254
Xencor
XNCR
$1.45B
$1.89M 0.13%
43,303
+4,090
+10% +$169K
PETQ
255
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$1.82M 0.12%
47,300
-26,456
-36% -$819K
VTLE
256
DELISTED
Vital Energy
VTLE
$1.81M 0.12%
91,776
+9,642
+12% +$124K
MTH icon
257
Meritage Homes
MTH
$4.78B
$1.8M 0.12%
43,400
-84,200
-66% -$3.98M
CWT icon
258
California Water Service
CWT
$3.1B
$1.79M 0.12%
33,226
+1,948
+6% +$96K
GTHX
259
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$1.78M 0.12%
98,725
-41,199
-29% -$616K
LILAK icon
260
Liberty Latin America Class C
LILAK
$1.69B
$1.76M 0.12%
174,680
+52,917
+43% +$523K
PATK icon
261
Patrick Industries
PATK
$2.87B
$1.73M 0.12%
37,985
-5,212
-12% -$221K
GBX icon
262
The Greenbrier Companies
GBX
$1.57B
$1.72M 0.12%
47,236
+1,037
+2% +$34.2K
MGNX icon
263
MacroGenics
MGNX
$233M
$1.69M 0.11%
74,000
FIX icon
264
Comfort Systems
FIX
$53.5B
$1.69M 0.11%
+32,025
New +$1.66M
FCF icon
265
First Commonwealth Financial
FCF
$2.2B
$1.63M 0.11%
149,400
+18,851
+14% +$181K
LASR icon
266
nLIGHT
LASR
$3.33B
$1.61M 0.11%
49,450
+7,926
+19% +$224K
NTGR icon
267
NETGEAR
NTGR
$612M
$1.58M 0.11%
38,900
+7,183
+23% +$244K
CNST
268
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$1.58M 0.11%
+54,800
New +$1.38M
AX icon
269
Axos Financial
AX
$5.58B
$1.52M 0.1%
40,617
-5,283
-12% -$167K
FSS icon
270
Federal Signal
FSS
$6.82B
$1.5M 0.1%
45,117
+3,747
+9% +$118K
DNLI icon
271
Denali Therapeutics
DNLI
$3.79B
$1.48M 0.1%
17,713
-54,224
-75% -$3.28M
MEOH icon
272
Methanex
MEOH
$4.23B
$1.47M 0.1%
31,834
-31,866
-50% -$1.15M
NVDA icon
273
NVIDIA
NVDA
$4.6T
$1.46M 0.1%
+112,120
New +$1.5M
CCS icon
274
Century Communities
CCS
$1.98B
$1.46M 0.1%
33,342
-20,064
-38% -$884K
TCMD icon
275
Tactile Systems Technology
TCMD
$618M
$1.45M 0.1%
+32,279
New +$1.28M

Similar funds

PDT Partners's Q4 2020 Portfolio in Review

As of Q4 2020, PDT Partners held 913 positions worth $1.48B, down 2.3% from $1.51B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.

PDT Partners withdrew a net $328M in Q4 2020, closing 241 positions and reducing 301 holdings. Its most notable exit was Lam Research, an estimated $8.46M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, PDT Partners opened a new position in ScottsMiracle-Gro worth $6.59M.

  • PDT Partners's largest Q4 2020 buy was ScottsMiracle-Gro: 33,110 shares worth $6.59M.
  • PDT Partners added most to Arch Capital in Q4 2020, an estimated $5.65M increase.
  • PDT Partners's biggest Q4 2020 reduction was Ferrari, cutting an estimated $12.2M.
  • PDT Partners fully exited Lam Research in Q4 2020, selling an estimated $8.46M.
  • PDT Partners's ten largest holdings make up 6.7% of its $1.48B portfolio in Q4 2020.
  • PDT Partners opened 211 new positions and closed 241 in Q4 2020.
  • PDT Partners's portfolio value fell 2.3% quarter-over-quarter to $1.48B.

Based on PDT Partners's 13F filing for Q4 2020, filed 16 Feb 2021.